(-)-anisomycin multiple interactions ISO RGD:1622387 6480464 MAPK14 protein affects the reaction [Anisomycin results in increased activity of MAPKAPK2 protein] CTD PMID:10704466 (-)-anisomycin increases activity ISO RGD:1622387 6480464 Anisomycin results in increased activity of MAPKAPK2 protein CTD PMID:10704466 1,2-dimethylhydrazine increases expression ISO RGD:1622387 6480464 1, 2-Dimethylhydrazine results in increased expression of MAPKAPK2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1622387 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MAPKAPK2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1622387 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPKAPK2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1622387 6480464 Ethinyl Estradiol results in increased expression of MAPKAPK2 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:1622387 6480464 Estradiol affects the expression of MAPKAPK2 mRNA CTD PMID:15598610 17beta-estradiol increases expression ISO RGD:1606829 6480464 Estradiol results in increased expression of MAPKAPK2 mRNA CTD PMID:23094148 17beta-estradiol decreases expression ISO RGD:1622387 6480464 Estradiol results in decreased expression of MAPKAPK2 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAPKAPK2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1622387 6480464 Tetrachlorodibenzodioxin affects the expression of MAPKAPK2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1622387 6480464 Tetrachlorodibenzodioxin results in increased expression of MAPKAPK2 mRNA CTD PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1622387 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPKAPK2 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of MAPKAPK2 mRNA CTD PMID:21346803 2-nitrotoluene increases expression EXP 6480464 2-nitrotoluene results in increased expression of MAPKAPK2 mRNA CTD PMID:16460773 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1606829 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAPKAPK2 mRNA CTD PMID:28628672 5-aza-2'-deoxycytidine affects methylation ISO RGD:1606829 6480464 Decitabine affects the methylation of MAPKAPK2 gene CTD PMID:17630775 7H-xanthine multiple interactions EXP 6480464 3 more ... CTD PMID:26374991 9H-xanthine multiple interactions EXP 6480464 3 more ... CTD PMID:26374991 aflatoxin B1 decreases methylation ISO RGD:1606829 6480464 Aflatoxin B1 results in decreased methylation of MAPKAPK2 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1606829 6480464 Tretinoin results in increased expression of MAPKAPK2 mRNA CTD PMID:17218384 all-trans-retinoic acid multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [Tretinoin results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:30709899 all-trans-retinoic acid increases phosphorylation ISO RGD:1606829 6480464 Tretinoin results in increased phosphorylation of MAPKAPK2 protein CTD PMID:30709899 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAPKAPK2 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one decreases activity EXP 6480464 pyrazolanthrone results in decreased activity of MAPKAPK2 protein CTD PMID:15196213 aripiprazole multiple interactions ISO RGD:1606829 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of MAPKAPK2 mRNA CTD PMID:31476115 arsenite(3-) multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [arsenite results in increased activity of MAPKAPK2 protein] CTD PMID:9545260 arsenite(3-) multiple interactions ISO RGD:1622387 6480464 SB 203580 inhibits the reaction [arsenite results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:14511371 arsenite(3-) increases activity ISO RGD:1606829 6480464 arsenite results in increased activity of MAPKAPK2 protein CTD PMID:9545260 arsenite(3-) increases phosphorylation ISO RGD:1622387 6480464 arsenite results in increased phosphorylation of MAPKAPK2 protein CTD PMID:14511371 arsenous acid decreases expression ISO RGD:1606829 6480464 Arsenic Trioxide results in decreased expression of MAPKAPK2 mRNA CTD PMID:20458559 arsenous acid multiple interactions ISO RGD:1606829 6480464 MAPK11 protein modified form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein], SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein] CTD PMID:12239215 arsenous acid increases activity ISO RGD:1606829 6480464 Arsenic Trioxide results in increased activity of MAPKAPK2 protein CTD PMID:12239215 atrazine multiple interactions ISO RGD:1606829 6480464 [Atrazine co-treated with Arsenates] results in increased expression of MAPKAPK2 mRNA CTD PMID:18585445 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of MAPKAPK2 mRNA CTD PMID:17905399 benzene decreases expression ISO RGD:1606829 6480464 Benzene results in decreased expression of MAPKAPK2 mRNA CTD PMID:33064461 benzene increases expression ISO RGD:1606829 6480464 Benzene results in increased expression of MAPKAPK2 mRNA CTD PMID:19162166 benzo[a]pyrene affects methylation ISO RGD:1606829 6480464 Benzoapyrene affects the methylation of MAPKAPK2 promoter CTD PMID:27901495 benzoates decreases expression ISO RGD:1606829 6480464 Benzoates analog results in decreased expression of MAPKAPK2 mRNA CTD PMID:29472718 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1606829 6480464 MAPKAPK2 protein affects the reaction [Mustard Gas results in increased expression of TNF mRNA] more ... CTD PMID:23851002 bis(2-chloroethyl) sulfide affects response to substance ISO RGD:1606829 6480464 MAPKAPK2 protein affects the susceptibility to Mustard Gas CTD PMID:23851002 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAPKAPK2 mRNA CTD PMID:25181051 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAPKAPK2 gene CTD PMID:28505145 bisphenol A decreases methylation ISO RGD:1622387 6480464 bisphenol A results in decreased methylation of MAPKAPK2 promoter CTD PMID:27312807 bisphenol F multiple interactions ISO RGD:1606829 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAPKAPK2 mRNA CTD PMID:28628672 bortezomib decreases expression ISO RGD:1606829 6480464 Bortezomib results in decreased expression of MAPKAPK2 mRNA CTD PMID:20977926 bromochloroacetic acid increases expression EXP 6480464 bromochloroacetic acid results in increased expression of MAPKAPK2 mRNA CTD PMID:16460773 butan-1-ol multiple interactions ISO RGD:1606829 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MAPKAPK2 mRNA CTD PMID:29432896 cadmium dichloride multiple interactions ISO RGD:1622387 6480464 MT1 affects the reaction [Cadmium Chloride results in increased expression of MAPKAPK2 mRNA], MT2 affects the reaction [Cadmium Chloride results in increased expression of MAPKAPK2 mRNA] CTD PMID:11958953 cadmium dichloride multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:9822662 cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAPKAPK2 protein CTD PMID:9822662 cadmium dichloride increases phosphorylation ISO RGD:1606829 6480464 Cadmium Chloride results in increased phosphorylation of MAPKAPK2 protein CTD PMID:21219922 cadmium dichloride multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:21219922 cadmium dichloride increases expression ISO RGD:1622387 6480464 Cadmium Chloride results in increased expression of MAPKAPK2 mRNA CTD PMID:11958953 carbamazepine affects expression ISO RGD:1606829 6480464 Carbamazepine affects the expression of MAPKAPK2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1622387 6480464 Nanotubes, Carbon analog results in increased expression of MAPKAPK2 mRNA CTD PMID:25554681 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of MAPKAPK2 mRNA CTD PMID:19441803 cisplatin increases phosphorylation ISO RGD:1622387 6480464 Cisplatin results in increased phosphorylation of MAPKAPK2 protein CTD PMID:22006019 clofibrate decreases expression ISO RGD:1622387 6480464 Clofibrate results in decreased expression of MAPKAPK2 mRNA CTD PMID:17585979 coniferyl aldehyde multiple interactions ISO RGD:1606829 6480464 MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein], MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] CTD PMID:26275128 copper(II) sulfate increases expression ISO RGD:1606829 6480464 Copper Sulfate results in increased expression of MAPKAPK2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1606829 6480464 Asbestos, Crocidolite results in increased expression of MAPKAPK2 mRNA CTD PMID:25757056 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of MAPKAPK2 mRNA CTD PMID:21865292 D-glucitol increases activity ISO RGD:1606829 6480464 Sorbitol results in increased activity of MAPKAPK2 protein CTD PMID:9545260 D-glucitol increases phosphorylation ISO RGD:1606829 6480464 Sorbitol results in increased phosphorylation of MAPKAPK2 protein CTD PMID:15362974 D-glucitol multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [Sorbitol results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:15362974 dexamethasone multiple interactions ISO RGD:1606829 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAPKAPK2 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:1606829 6480464 MAPK11 protein modified form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein], SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein] CTD PMID:12239215 diarsenic trioxide increases activity ISO RGD:1606829 6480464 Arsenic Trioxide results in increased activity of MAPKAPK2 protein CTD PMID:12239215 diarsenic trioxide decreases expression ISO RGD:1606829 6480464 Arsenic Trioxide results in decreased expression of MAPKAPK2 mRNA CTD PMID:20458559 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MAPKAPK2 mRNA CTD PMID:21266533 diethylstilbestrol increases expression ISO RGD:1622387 6480464 Diethylstilbestrol results in increased expression of MAPKAPK2 mRNA CTD PMID:21041162 dioxygen multiple interactions ISO RGD:1622387 6480464 [sulforafan affects the susceptibility to Oxygen] which affects the expression of MAPKAPK2 mRNA CTD PMID:30529165 ethanol multiple interactions ISO RGD:1622387 6480464 SB 203580 inhibits the reaction [Ethanol results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:27270636 ethanol increases phosphorylation ISO RGD:1622387 6480464 Ethanol results in increased phosphorylation of MAPKAPK2 protein CTD PMID:27270636 etoposide multiple interactions ISO RGD:1622387 6480464 4-5-4-fluorophenyl-2-methylsulfanyl-3H-imidazol-4-ylpyridin-2-yl-1-phenylethylamine inhibits the reaction [Etoposide results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:17003255 etoposide increases phosphorylation ISO RGD:1622387 6480464 Etoposide results in increased phosphorylation of MAPKAPK2 protein CTD PMID:17003255 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of MAPKAPK2 mRNA CTD PMID:23962444 flurbiprofen multiple interactions ISO RGD:1606829 6480464 Flurbiprofen results in increased phosphorylation of and results in increased activity of MAPKAPK2 protein, MAPKAPK2 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] CTD PMID:18056468 folic acid multiple interactions ISO RGD:1622387 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MAPKAPK2 mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:1622387 6480464 Folic Acid results in decreased expression of MAPKAPK2 mRNA CTD PMID:25629700 geldanamycin increases expression ISO RGD:1606829 6480464 geldanamycin results in increased expression of MAPKAPK2 mRNA CTD PMID:26705709 glyphosate decreases expression ISO RGD:1606829 6480464 glyphosate results in decreased expression of MAPKAPK2 mRNA CTD PMID:31295307 hydrogen peroxide increases activity ISO RGD:1606829 6480464 Hydrogen Peroxide results in increased activity of MAPKAPK2 protein CTD PMID:9545260 hydroxytyrosol multiple interactions EXP 6480464 3, 4-dihydroxyphenylethanol inhibits the reaction [[Xanthine co-treated with XDH protein] results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:26374991 ibuprofen multiple interactions ISO RGD:1606829 6480464 Ibuprofen results in increased phosphorylation of and results in increased activity of MAPKAPK2 protein, MAPKAPK2 protein promotes the reaction [Ibuprofen results in increased expression of NGFR protein] CTD PMID:18056468 indometacin multiple interactions ISO RGD:1606829 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAPKAPK2 mRNA CTD PMID:28628672 lead diacetate increases expression ISO RGD:1622387 6480464 lead acetate results in increased expression of MAPKAPK2 mRNA CTD PMID:21322097 lipopolysaccharide increases phosphorylation ISO RGD:1606829 6480464 Lipopolysaccharides results in increased phosphorylation of MAPKAPK2 protein CTD PMID:29925859 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of MAPKAPK2 mRNA CTD PMID:16401727 , PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:1606829 6480464 3-4-methylphenylsulfonyl-2-propenenitrile promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPKAPK2 protein] more ... CTD PMID:21135123 lipopolysaccharide multiple interactions ISO RGD:1622387 6480464 MAPKAPK2 protein affects the reaction [Lipopolysaccharides affects the localization of RELA protein] more ... CTD PMID:16431125 more ... lipopolysaccharide increases activity ISO RGD:1622387 6480464 Lipopolysaccharides results in increased activity of MAPKAPK2 protein CTD PMID:16431125 , PMID:21494017 methotrexate affects expression ISO RGD:1606829 6480464 Methotrexate affects the expression of MAPKAPK2 mRNA CTD PMID:19100307 methotrexate multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [Methotrexate results in increased expression of MAPKAPK2 protein] CTD PMID:19100307 methotrexate increases expression ISO RGD:1606829 6480464 Methotrexate results in increased expression of MAPKAPK2 protein CTD PMID:19100307 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of MAPKAPK2 mRNA CTD PMID:17905399 N-acetyl-L-cysteine multiple interactions ISO RGD:1622387 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:21911445 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine increases expression EXP 6480464 Ranitidine results in increased expression of MAPKAPK2 mRNA CTD PMID:16415329 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of MAPKAPK2 mRNA CTD PMID:16401727 , PMID:16415329 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of MAPKAPK2 mRNA CTD PMID:24136188 nickel subsulfide decreases expression ISO RGD:1606829 6480464 nickel subsulfide results in decreased expression of MAPKAPK2 mRNA CTD PMID:12760830 nickel sulfate multiple interactions ISO RGD:1606829 6480464 [Potassium Dichromate co-treated with nickel sulfate] results in increased phosphorylation of MAPKAPK2 protein CTD PMID:20493934 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of MAPKAPK2 mRNA CTD PMID:24136188 ozone increases expression ISO RGD:1606829 6480464 Ozone results in increased expression of MAPKAPK2 mRNA CTD PMID:31476115 ozone multiple interactions ISO RGD:1606829 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of MAPKAPK2 mRNA, LY2228820 inhibits the reaction [Ozone results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:29925859 , PMID:31476115 ozone increases phosphorylation ISO RGD:1606829 6480464 Ozone results in increased phosphorylation of MAPKAPK2 protein CTD PMID:29925859 paracetamol affects expression ISO RGD:1622387 6480464 Acetaminophen affects the expression of MAPKAPK2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1606829 6480464 Acetaminophen results in increased expression of MAPKAPK2 mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:1606829 6480464 Acetaminophen results in decreased expression of MAPKAPK2 mRNA CTD PMID:26690555 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of MAPKAPK2 mRNA CTD PMID:19162173 phorbol 13-acetate 12-myristate increases activity ISO RGD:1606829 6480464 Tetradecanoylphorbol Acetate results in increased activity of MAPKAPK2 protein CTD PMID:9545260 potassium dichromate multiple interactions ISO RGD:1606829 6480464 [Potassium Dichromate co-treated with nickel sulfate] results in increased phosphorylation of MAPKAPK2 protein CTD PMID:20493934 potassium dichromate increases phosphorylation ISO RGD:1606829 6480464 Potassium Dichromate results in increased phosphorylation of MAPKAPK2 protein CTD PMID:20493934 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Xanthine co-treated with XDH protein] results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:26374991 raloxifene multiple interactions ISO RGD:1606829 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MAPKAPK2 mRNA CTD PMID:19059307 ranitidine increases expression EXP 6480464 Ranitidine results in increased expression of MAPKAPK2 mRNA CTD PMID:16415329 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of MAPKAPK2 mRNA CTD PMID:16401727 , PMID:16415329 retinyl acetate increases expression ISO RGD:1622387 6480464 retinol acetate results in increased expression of MAPKAPK2 mRNA CTD PMID:16772331 rifampicin increases phosphorylation ISO RGD:1606829 6480464 Rifampin results in increased phosphorylation of MAPKAPK2 protein CTD PMID:21127053 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAPKAPK2 mRNA CTD PMID:28374803 rottlerin decreases activity ISO RGD:1606829 6480464 rottlerin results in decreased activity of MAPKAPK2 protein CTD PMID:10998351 SB 203580 multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein] more ... CTD PMID:12239215 more ... SB 203580 decreases expression ISO RGD:1622387 6480464 SB 203580 results in decreased expression of MAPKAPK2 protein modified form CTD PMID:28329830 SB 203580 increases phosphorylation ISO RGD:1622387 6480464 SB 203580 results in increased phosphorylation of MAPKAPK2 protein CTD PMID:27270636 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPKAPK2 protein], SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK2 protein] CTD PMID:9288946 more ... SB 203580 multiple interactions ISO RGD:1622387 6480464 SB 203580 affects the reaction [MAPK14 protein affects the reaction [sodium arsenite results in increased activity of MAPKAPK2 protein]] more ... CTD PMID:10704466 more ... SB 203580 decreases phosphorylation ISO RGD:1606829 6480464 SB 203580 results in decreased phosphorylation of MAPKAPK2 protein CTD PMID:19376214 , PMID:30709899 sodium arsenate increases expression ISO RGD:1622387 6480464 sodium arsenate results in increased expression of MAPKAPK2 mRNA CTD PMID:30953684 sodium arsenite multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK2 protein] more ... CTD PMID:12547826 more ... sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of MAPKAPK2 protein CTD PMID:9288946 , PMID:9877156 sodium arsenite multiple interactions EXP 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK2 protein] CTD PMID:9288946 , PMID:9877156 sodium arsenite increases expression ISO RGD:1622387 6480464 sodium arsenite results in increased expression of MAPKAPK2 mRNA CTD PMID:11353140 sodium arsenite increases activity ISO RGD:1622387 6480464 sodium arsenite results in increased activity of MAPKAPK2 protein CTD PMID:10704466 sodium arsenite multiple interactions ISO RGD:1622387 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of MAPKAPK2 protein] more ... CTD PMID:10704466 , PMID:21911445 sodium arsenite increases phosphorylation ISO RGD:1606829 6480464 sodium arsenite results in increased phosphorylation of MAPKAPK2 protein CTD PMID:15362974 sodium arsenite increases activity ISO RGD:1606829 6480464 sodium arsenite results in increased activity of MAPKAPK2 protein CTD PMID:12547826 sodium dichromate decreases expression ISO RGD:1606829 6480464 sodium bichromate results in decreased expression of MAPKAPK2 mRNA CTD PMID:12760830 sodium fluoride increases phosphorylation ISO RGD:1606829 6480464 Sodium Fluoride results in increased phosphorylation of MAPKAPK2 protein CTD PMID:19376214 sodium fluoride decreases expression ISO RGD:1622387 6480464 Sodium Fluoride results in decreased expression of MAPKAPK2 mRNA CTD PMID:27862939 sodium fluoride multiple interactions ISO RGD:1606829 6480464 SB 203580 inhibits the reaction [Sodium Fluoride results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:19376214 Soman increases expression EXP 6480464 Soman results in increased expression of MAPKAPK2 mRNA CTD PMID:19281266 streptozocin multiple interactions ISO RGD:1622387 6480464 telmisartan inhibits the reaction [Streptozocin results in increased expression of MAPKAPK2 protein modified form] CTD PMID:21381899 streptozocin increases expression ISO RGD:1622387 6480464 Streptozocin results in increased expression of MAPKAPK2 protein modified form CTD PMID:21381899 sulfates affects methylation ISO RGD:1606829 6480464 Sulfates affects the methylation of MAPKAPK2 promoter CTD PMID:25395096 sulforaphane multiple interactions ISO RGD:1622387 6480464 [sulforafan affects the susceptibility to Oxygen] which affects the expression of MAPKAPK2 mRNA CTD PMID:30529165 sunitinib increases expression ISO RGD:1606829 6480464 Sunitinib results in increased expression of MAPKAPK2 mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:1606829 6480464 tamibarotene results in increased expression of MAPKAPK2 mRNA CTD PMID:17229644 tamoxifen increases expression ISO RGD:1622387 6480464 Tamoxifen results in increased expression of MAPKAPK2 mRNA CTD PMID:25123088 tamoxifen multiple interactions ISO RGD:1606829 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAPKAPK2 mRNA CTD PMID:19059307 telmisartan multiple interactions ISO RGD:1622387 6480464 telmisartan inhibits the reaction [Streptozocin results in increased expression of MAPKAPK2 protein modified form] CTD PMID:21381899 tetrachloromethane increases expression ISO RGD:1622387 6480464 Carbon Tetrachloride results in increased expression of MAPKAPK2 mRNA CTD PMID:31919559 thimerosal decreases expression ISO RGD:1606829 6480464 Thimerosal results in decreased expression of MAPKAPK2 mRNA CTD PMID:27188386 titanium dioxide decreases expression ISO RGD:1622387 6480464 titanium dioxide results in decreased expression of MAPKAPK2 mRNA CTD PMID:29264374 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of MAPKAPK2 mRNA CTD PMID:17905399 trichostatin A decreases expression ISO RGD:1606829 6480464 trichostatin A results in decreased expression of MAPKAPK2 mRNA CTD PMID:24935251 trovafloxacin multiple interactions ISO RGD:1622387 6480464 SB 203580 inhibits the reaction [trovafloxacin results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:24525298 trovafloxacin increases phosphorylation ISO RGD:1622387 6480464 trovafloxacin results in increased phosphorylation of MAPKAPK2 protein CTD PMID:24525298 urethane increases expression ISO RGD:1606829 6480464 Urethane results in increased expression of MAPKAPK2 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of MAPKAPK2 mRNA CTD PMID:24136188 vorinostat decreases expression ISO RGD:1606829 6480464 vorinostat results in decreased expression of MAPKAPK2 mRNA CTD PMID:27188386